Today: 7 February 2026
Subscribe
Browse Category

NYSE:DHR News 12 December 2025 - 2 February 2026

Danaher stock price jumps 2% to $223 as DHR snaps losing streak in late trade

Danaher stock price jumps 2% to $223 as DHR snaps losing streak in late trade

Danaher shares closed up 2.1% at $223.42 Monday, ending a four-day slide and holding steady after hours. The company forecasts 2026 core revenue growth of 3% to 6% and adjusted EPS of $8.35 to $8.50. Investors are watching for signs of renewed lab and pharma spending amid a U.S. government shutdown that has delayed key economic data.
2 February 2026
·····
Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher shares edged up 0.1% to $219.83 Friday after steep losses earlier in the week. The company reported Q4 revenue of $6.84 billion and adjusted EPS of $2.23, with 2026 earnings guidance in line with analyst forecasts. Investors remain cautious amid weak academic research funding and recent stock swings. Vanguard disclosed an 8.63% stake in Danaher as of Dec. 31.
30 January 2026
········
Danaher stock slides again after outlook: what DHR investors are watching next

Danaher stock slides again after outlook: what DHR investors are watching next

Danaher shares fell 2.2% to $219.49 Thursday after its 2026 profit outlook matched analyst estimates. Fourth-quarter revenue rose 4.5% to $6.8 billion, with adjusted earnings at $2.23 per share. CEO Rainer Blair said China diagnostics revenue declined only slightly in Q4, improving from previous quarters. Investors remain cautious as sector peers warn of continued weakness in academic research spending.
29 January 2026
·····
Danaher (DHR) stock slides nearly 5% after earnings beat as 2026 outlook lands “in line”

Danaher (DHR) stock slides nearly 5% after earnings beat as 2026 outlook lands “in line”

Danaher shares fell 4.8% to $224.54 after its 2026 profit outlook matched analyst expectations. The company beat fourth-quarter profit and revenue estimates, posting $6.8 billion in revenue and $2.23 per share in adjusted earnings. Trading volume more than doubled its 50-day average. Investors focused on the pace of recovery and upcoming results from rival Thermo Fisher.
29 January 2026
·····
Thermo Fisher (TMO) stock jumps as Stifel lifts target to $700; earnings next

Thermo Fisher (TMO) stock jumps as Stifel lifts target to $700; earnings next

New York, Jan 9, 2026, 19:08 EST — After-hours Thermo Fisher Scientific Inc (TMO.N) shares climbed roughly 2% on Friday following a price target boost from Stifel, which called for a “solid year” ahead as biopharma demand picked up. The stock ended the day up $12.45, closing at $618.86. (GuruFocus) The timing is crucial. Investors are gearing up for Thermo Fisher’s Q4 and full-year earnings, set for Jan. 29, when the company is likely to update its 2026 guidance. (Thermo Fisher Scientific) Coming up sooner, CEO Marc Casper will speak at the J.P. Morgan Healthcare Conference on Jan. 13. This
10 January 2026
·······
Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

NEW YORK, Jan 7, 2026, 21:13 EST — Market closed Danaher Corporation (DHR.N) stock slipped on Wednesday, closing at $235.60, down 0.42%. The shares were last up 0.16% in extended trading. The life-sciences and diagnostics group is heading into a crowded calendar. Danaher said Chief Executive Rainer M. Blair will present at the J.P. Morgan Healthcare Conference in San Francisco on Jan. 13, and it has set its fourth-quarter earnings call for Jan. 28. Evercore ISI analyst Vijay Kumar raised his 12-month price target — an estimate of where a stock could trade — to $250 from $245 and kept
8 January 2026
·····
Danaher stock beats Wall Street dip as investors eye Fed minutes and Jan. 28 earnings

Danaher stock beats Wall Street dip as investors eye Fed minutes and Jan. 28 earnings

NEW YORK, December 29, 2025, 22:23 ET — Market closed Danaher Corp shares were last up about 0.1% at $230.63 on Monday, after trading between $229.26 and $231.77 during the session. The muted move still mattered for Danaher investors because the stock held up in a market that turned lower as the year winds down and liquidity thins, a setup that can amplify sector rotations. It also comes ahead of a key macro catalyst: the Federal Reserve’s December meeting minutes, due Tuesday, with traders pricing in additional rate cuts in 2026 as the U.S. dollar weakens into year-end. reuters.com U.S.
30 December 2025
·····
Danaher (DHR) Stock After Hours on Dec. 24, 2025: What Happened After the Early Close — and What to Know Before the Next Market Open

Danaher (DHR) Stock After Hours on Dec. 24, 2025: What Happened After the Early Close — and What to Know Before the Next Market Open

Danaher Corporation (NYSE: DHR) ended Wednesday, Dec. 24, 2025 on a quiet note in a holiday-shortened session, then drifted only slightly in after-hours trading. With U.S. markets closed on Christmas Day (Dec. 25) and set to reopen Friday, Dec. 26, the key “overnight” story for Danaher is less about a dramatic after-hours move — and more about calendar-driven factors (especially the ex‑dividend date) and a handful of headline items investors may see circulating before the next open. New York Stock Exchange+1 Danaher stock price after the bell (Dec. 24, 2025) Because Christmas Eve had an early 1:00 p.m. ET close
25 December 2025
····
Danaher Stock (DHR) News Today: BofA Lifts Price Target to $265, Wells Fargo to $240 as 2026 Normalization Comes Into Focus

Danaher Stock (DHR) News Today: BofA Lifts Price Target to $265, Wells Fargo to $240 as 2026 Normalization Comes Into Focus

Danaher Corporation (NYSE: DHR) is back in the spotlight on Monday, December 15, 2025, after two fresh Wall Street updates pushed Danaher stock back into the “what’s next” conversation for life-science and diagnostics investors. In afternoon trading, DHR hovered around $227 per share, modestly higher on the day. The bigger story isn’t a dramatic price move—it’s the shift in tone among analysts: multiple firms are positioning 2026 as a potential “normalization year” for demand trends across life sciences tools and diagnostics, with Danaher seen as one of the large-cap bellwethers. Below is a full, publication-ready breakdown of today’s news, forecasts,
15 December 2025
·····
Danaher Stock DHR: What Happened This Week, Latest News, and the Week-Ahead Outlook

Danaher Stock DHR: What Happened This Week, Latest News, and the Week-Ahead Outlook

Updated: December 12, 2025 (U.S. market close) Danaher Corporation stock (NYSE: DHR) finished the week with a sharp Friday pullback after a strong midweek rebound—leaving investors with the same big question heading into next week: was this just normal volatility in a high-quality healthcare name, or a sign the market is repricing the 2026 recovery story? As of Friday’s close, Danaher shares fell about 2.6% to $226.33, underperforming both the broader market and several large-cap medical peers on a risk-off session. MarketWatch Below is a detailed look at the most important Danaher stock headlines from the last few days, what
13 December 2025
····
Danaher Corporation Stock (DHR) Today: Latest News, Analyst Forecasts, and What Investors Are Watching on Dec. 12, 2025

Danaher Corporation Stock (DHR) Today: Latest News, Analyst Forecasts, and What Investors Are Watching on Dec. 12, 2025

Danaher Corporation (NYSE: DHR) is trading near the $231 level on Friday, Dec. 12, 2025, as fresh valuation takes, analyst coverage, and institutional positioning keep the life-sciences and diagnostics leader on investors’ screens. Here’s a complete roundup of today’s key developments, the newest forecasts, and the catalysts that could shape DHR’s next move. DHR stock price today (Dec. 12, 2025) Danaher shares were $231.54 in the latest available quote on Dec. 12 (15:50 UTC), down $0.83 (-0.36%) on the day. The session’s intraday range was roughly $230.09 to $232.82, with volume around 713K shares at that time. For longer-term context,
12 December 2025
····
1 2

Stock Market Today

Meta stock faces an AI split: ad gains vs a $135 billion bill

Meta stock faces an AI split: ad gains vs a $135 billion bill

7 February 2026
Meta shares dropped 1.3% to $661.46 on Friday after the company projected 2026 capital spending of up to $135 billion, raising investor concerns over cash flow. Meta reported Q4 revenue of $59.89 billion, up 24% year-over-year, with ad impressions rising 18%. Analysts remain divided on whether AI-driven ad gains can offset the steep spending ramp.
IAG share price jumps toward a 52-week peak — what to watch before London reopens

IAG share price jumps toward a 52-week peak — what to watch before London reopens

7 February 2026
IAG shares rose 4.33% to 438.50 pence Friday, near their 52-week high, ahead of full-year results due later this month. The company reported 162,073,135 treasury shares and total voting rights of 4,565,128,012. Brent crude fell 2.2% Thursday to $67.93 a barrel. South Europe Ground Services logged 712,340 operations in 2025 and seeks approval to operate in Portugal.
Go toTop